Precision Oncology delivers the novel science of biomarkers and expertise in managing oncology clinical trials all under a single project leadership team. The critical interplay between biomarker data and clinical data in informing ongoing trial strategy and execution requires a cohesive approach.
In partnership with our sponsors we create a comprehensive biomarker strategy that leverages our decades of scientific and clinical expertise in Oncology and Immunology. We go beyond providing assay menus and list of instruments and work with our sponsors to develop a holistic biomarker strategy across immune, cell-based, imaging and molecular markers. Our strategies are fit-for-purpose with a study’s needs and maximize the potential to bring deeper and real-time insights to trials.
Precision Oncology was built to deliver on the evolving needs of biomarker-based drug development by offering these services either as a complete package or a-la-carte.
Click here for more information on our oncology biomarker services
The need for well-controlled biospecimen management is often severely underestimated. As studies scale from single to multiple sites, there can be a dramatic drop in the collection and processing of precious study samples in a consistent and reproducible manner. With this in mind, Precision Oncology created state-of-the-art infrastructure and processes to track, receive and process samples consistently across sites. We do this globally and with a relentless focus on quality, logistics and standardization. Highlights of our infrastructure include...Read More
A comprehensive biomarker strategy covers a range of specialty assays that are fit-for-purpose, and can be custom-designed and fully validated, if needed. We can deliver these assays as individual pieces or as a package of assays that are analyzed together via our propriety analytics platform, delivering unprecedented insights to sponsors...Read More
Data Analysis via PATH™
Precision Oncology has responded to the demands of biomarker-guided drug development by engineering the PATH™ Analytics Platform, a cloud-based predictive analytics engine and knowledge-generation platform specifically engineered to address the complexities of high-throughput, high-content biological data in the context of translational research...Read More
Companion Diagnostic Development
For any biomarkers that demonstrate promise as a companion or complementary diagnostic, Precision Oncology provides services to enable the complete development and global registration of these diagnostics. To date, our team has completed...Read More